|
Recently, Advanced Cell Technology (ACT) announced that their clinical trial of stem cells was ramping up to begin the higher level dosing. In that report, they noted that a new group of patients were receiving a single injection of 150,000 stem cell derived retinal cells. In the same press release, they noted that there has been a trend toward perceived improved vision and one patient who had gained a measurable 7 letter improvement.
Last week, a casual remark by one of the principals of the company raised hopes that a much greater improvement had been observed. One patient went from 20/400 to 20/40.
|
|
Read more...
|